Tenaya Therapeutics Prepares New TN-201 Gene Therapy Data for Genetic Heart Disease
SOUTH SAN FRANCISCO, Calif., June 2, 2026 Tenaya Therapeutics announced that it will present new interim clinical data from...
Biopharma News
Advertisement
AstraZeneca’s FASENRA Wins FDA Approval for HES
WILMINGTON, Del., May 14, 2026 AstraZeneca announced that the U.S. Food and Drug Administration has approved FASENRA® (benralizumab) for...
AstraZeneca VOLGA Trial Boosts Bladder Cancer Survival
CAMBRIDGE, UK, May 14, 2026 AstraZeneca announced positive interim results from the global Phase III VOLGA trial, demonstrating that...
Galmed Reports 500% Bioavailability Boost for Aramchol
RAMAT-GAN, Israel, May 14, 2026 Galmed Pharmaceuticals Ltd. announced positive results from its first-in-human pharmacokinetics study evaluating the oral...
Protara Reports Strong Phase 2 NMIBC Trial Results
NEW YORK, May 15, 2026 Protara Therapeutics, Inc. announced positive updated 12-month data from the fully enrolled BCG-Naïve cohort...
Advertisements
Biogen Reports Breakthrough Tau Therapy Alzheimer Data
CAMBRIDGE, Mass., May 14, 2026 Biogen Inc. has announced promising topline results from its Phase 2 CELIA study evaluating...
Stealth BioTherapeutics Expands Access with Mito Assist™ and AnovoRx Partnership
NEEDHAM, Mass., October 9, 2025 — Stealth BioTherapeutics Inc. has announced the launch of Mito Assist™, a comprehensive patient...
Adcendo Secures FDA Fast Track for ADCE-D01 Targeting Soft Tissue Sarcoma
COPENHAGEN, Denmark, Oct. 9, 2025 – (cGxP.wire) – Adcendo ApS, a biotechnology company pioneering first- and best-in-class antibody-drug conjugates...
Advertisement
